Description

-Bta--D-Glucopyranosiduronic Acid, 5,7-Dimethyl-2-(Methylamino)-4-(3-Pyridinylmethyl)-6-Benzothiazolyl (9Ci) is a sophisticated benzothiazole derivative with a glucuronic acid moiety, representing a key intermediate in advanced pharmaceutical research and development. Its complex molecular architecture makes it a critical building block for synthesizing novel therapeutic agents, particularly in targeted drug discovery programs. This compound is essential for research chemists and process development scientists in the pharmaceutical and biotechnology industries seeking to develop new chemical entities with enhanced bioavailability and metabolic profiles.

Application

• Pharmaceutical Intermediate: Serves as a crucial precursor in the synthesis of novel drug candidates, particularly for central nervous system (CNS) and metabolic disorder targets.
• Medicinal Chemistry Research: Used as a scaffold for structure-activity relationship (SAR) studies to optimize potency and selectivity of lead compounds.
• Prodrug Development: The glucuronic acid component is valuable for designing prodrugs aimed at improving water solubility and targeted release.
• Bioconjugation: Potential use in creating chemical probes or antibody-drug conjugates (ADCs) for diagnostic or therapeutic applications.
• Enzyme Inhibition Studies: Employed in biochemical assays to study and develop inhibitors for specific enzymatic pathways.
• Reference Standard: Used as an analytical standard in quality control laboratories for method development and validation.

Basic Information

Item	Detail
Product Name	-Bta--D-Glucopyranosiduronic Acid, 5,7-Dimethyl-2-(Methylamino)-4-(3-Pyridinylmethyl)-6-Benzothiazolyl (9Ci)
CAS No.	157192-08-0
Molecular Formula	C24H27N3O7S
Molecular Weight	501.56 g/mol
Synonyms	5,7-Dimethyl-2-(methylamino)-4-[(pyridin-3-yl)methyl]-6-benzothiazolyl β-D-glucopyranosiduronic acid; 157192-08-0; Benzothiazole glucuronide derivative; 4-(3-Pyridinylmethyl)-5,7-dimethyl-2-(methylamino)-6-benzothiazolyl β-D-glucopyranosiduronic acid; β-D-Glucopyranosiduronic acid, 5,7-dimethyl-2-(methylamino)-4-(3-pyridinylmethyl)-6-benzothiazolyl-; SCHEMBL23833019; DTXSID70731892
EINECS	Contact for details

Quality Control

Our -Bta--D-Glucopyranosiduronic Acid, 5,7-Dimethyl-2-(Methylamino)-4-(3-Pyridinylmethyl)-6-Benzothiazolyl (9Ci) is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing to ensure identity, purity, and consistency, meeting the high standards required for pharmaceutical R&D. Certificates of Analysis (COA) detailing purity, impurities, and analytical methods (HPLC, NMR, MS) are provided with every shipment. We support compliance with cGMP and ISO 9001 guidelines for research materials.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This compound is hygroscopic (moisture-sensitive) and must be kept under anhydrous conditions. For long-term storage, consider storing under an inert atmosphere such as argon or nitrogen to prevent degradation.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (HPLC)	Conforms to reference standard
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 95.0%
Water Content (KF)	≤ 2.0%
Residual Solvents (GC)	Meets ICH Q3C guidelines
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.